• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

• Solvents and Organic Chemicals Organic Compounds Organosulfur compounds Thioacetals Monothioacetals

Professional Introduction to (ethylsulfanyl)(iodomethoxy)methanone (CAS No. 133217-42-2)

(ethylsulfanyl)(iodomethoxy)methanone, with the CAS number 133217-42-2, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, presents a promising platform for the development of novel therapeutic agents and biochemical probes.

The molecular structure of (ethylsulfanyl)(iodomethoxy)methanone consists of an ethylsulfanyl group and an iodomethoxy group attached to a methanone backbone. This configuration endows the compound with distinct chemical properties that make it valuable for various synthetic applications. The presence of both sulfur and iodine atoms in the molecule allows for diverse functionalization possibilities, enabling researchers to tailor its reactivity for specific biological targets.

In recent years, there has been a growing interest in exploring the potential of (ethylsulfanyl)(iodomethoxy)methanone as a building block in drug discovery. Its structural motifs are reminiscent of several bioactive molecules, suggesting that it could serve as a precursor for synthesizing compounds with therapeutic relevance. For instance, the ethylsulfanyl group can be readily modified to introduce additional pharmacophores, while the iodomethoxy group offers a handle for further functional transformations.

One of the most compelling aspects of this compound is its utility in cross-coupling reactions, which are fundamental to modern synthetic organic chemistry. The iodine atom in (ethylsulfanyl)(iodomethoxy)methanone can participate in palladium-catalyzed coupling reactions, such as Suzuki-Miyaura and Stille couplings, to form carbon-carbon bonds with other organic fragments. These reactions are widely employed in the synthesis of complex molecules, including those used in pharmaceuticals and agrochemicals.

Recent studies have highlighted the role of (ethylsulfanyl)(iodomethoxy)methanone in the development of kinase inhibitors. Kinases are enzymes that play crucial roles in cellular signaling pathways and are often implicated in various diseases, including cancer. By leveraging the reactivity of this compound, researchers have been able to design inhibitors that target specific kinase domains. The ethylsulfanyl group can be incorporated into the inhibitor to enhance binding affinity, while the iodomethoxy group provides a site for further modifications to optimize potency and selectivity.

The pharmaceutical industry has also explored the use of (ethylsulfanyl)(iodomethoxy)methanone as a scaffold for antiviral and antibacterial agents. Its structural features allow for interactions with viral proteases and bacterial enzymes, making it a viable candidate for developing novel treatments against infectious diseases. Additionally, its ability to undergo selective functionalization makes it adaptable for addressing emerging drug-resistant pathogens.

Beyond its applications in drug discovery, (ethylsulfanyl)(iodomethoxy)methanone has found utility in materials science and catalysis. The unique electronic properties of its sulfur and iodine-containing groups make it an interesting candidate for designing advanced materials with tailored optical and electronic characteristics. Furthermore, its role as a ligand or catalyst precursor has been investigated in various chemical transformations.

The synthesis of (ethylsulfanyl)(iodomethoxy)methanone presents both challenges and opportunities for synthetic chemists. While there are established methods for preparing similar compounds, optimizing yield and purity remains a key focus. Advances in synthetic techniques, such as transition metal catalysis and flow chemistry, have opened new avenues for improving the accessibility of this compound. These developments not only enhance its availability but also expand its potential applications across multiple scientific disciplines.

In conclusion, (ethylsulfanyl)(iodomethoxy)methanone (CAS No. 133217-42-2) is a versatile organic compound with significant potential in pharmaceutical research, materials science, and catalysis. Its unique structural features enable diverse functionalization strategies, making it a valuable tool for developing novel therapeutics and biochemical probes. As research continues to uncover new applications for this compound, its importance in advancing scientific knowledge is likely to grow.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)